The International Journal of Stroke is proud to announce a rise in our impact factor of 4.88 for the 2019 period from 4.46. We have moved up from 34 to 29/199 in Clinical Neurology and 11 to 9/65 in Peripheral Vascular disease categories.
An impact factor is not the only measurement of success for a truly global journal, and IJS as the flagship publication for the World Stroke Organization, takes this very seriously. We endeavour to amplify the voices of stroke from around the world using our various media channels. We use our journal, podcasts, social media and blog to build a strong and engaged stroke community. Our focus is the publication of high quality science, and we are pleased that this has been represented well in the accepted professional metrics. We will continue to build a dynamic and responsive journal, and associated media under our new editorial team. Thank you to our Associate Editors, Julie Bernhardt, Thorsten Steiner, Craig Anderson, Frank-Erik de Leeuw, and Michael Hill, for their huge efforts and our brilliant, active editorial board for this excellent IF outcome; and special thanks to Geoff Donnan, our ex-Editor-in-Chief, whose hard work this IF increase reflects.
Last month we hosted the IJS editorial board meeting online to great success, with two meetings allowing board members from throughout the world to attend. During the presentation we disclosed that female representation on the board has increased from 28% to 39%. During this time of global upheaval IJS recognises that representation matters, this means that we are actively seeking to maintain and grow the global nature of our board and increase our representation while advancing high quality science and research, an important balance.
Since the COVID-19 pandemic emerged we have taken the opportunity to publish a series of COVID papers in IJS. These are all freely available on our SAGE website, along with a podcast series for COVID-19 coverage, sign up to IJS podcasts via iTunes or Google Play.
Management of acute ischemic stroke in patients with COVID-19 infection: Report of an international panel
COVID-19 and stroke—A global World Stroke Organization perspective
Cerebrovascular disease is associated with increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature
Cerebral ischemic and hemorrhagic complications of coronavirus disease 2019
The global burden of stroke, and fluoxetine for stroke recovery
Underutilization of health care for strokes during the COVID-19 outbreak
COVID-19 and acute ischemic stroke – A case series from Dubai, UAE
Coronavirus disease 2019 and stroke in Iran: a case series and effects on stroke admissions
Impact of COVID-19 outbreak on ischemic stroke admissions and in-hospital mortality in North-West Spain
Stroke in COVID-19 patients—A case series from Italy
The Impact of the COVID-19 pandemic on a stroke center in Latin America
Achieving our vision of a life free from stroke is a task that WSO cannot achieve alone. We are committed to building our partnerships at the global, regional and national level to scale up and deliver improvements in prevention, treatment and support to reduce the burden of stroke.